Clinical trial
Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary…
NCT00256178 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00256178 |
|---|---|
| Title | Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia. |
| Official title | A Placebo-controlled, Double-blind, Randomized Study to Evaluate the Efficacy and Safety of TAK-475 50 mg and 100 mg Versus Placebo, When Co-administered With Simvastatin 20 mg or 40 mg in Subjects With Primary Dyslipidemia. |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | Lapaquistat acetate and simvastatin, Simvastatin |
| Enrollment | 411 |
| Start date | Oct 1, 2005 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Nov 21, 2005 |
| Last update posted | May 24, 2012 |
| Countries | Czechia, Estonia, Finland, Germany, Poland, South Africa, United Kingdom |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: